Does PEMBROLIZUMAB Cause Systemic inflammatory response syndrome? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Systemic inflammatory response syndrome have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
56
Reports of Systemic inflammatory response syndrome with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
15
Deaths
48
Hospitalizations
How Dangerous Is Systemic inflammatory response syndrome From PEMBROLIZUMAB?
Of the 56 reports, 15 (26.8%) resulted in death, 48 (85.7%) required hospitalization, and 6 (10.7%) were considered life-threatening.
Is Systemic inflammatory response syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Systemic inflammatory response syndrome?
DOXORUBICIN (161)
METHOTREXATE (158)
CYCLOPHOSPHAMIDE (153)
CYTARABINE (153)
METHYLPREDNISOLONE (117)
ADALIMUMAB (107)
RITUXIMAB (106)
PREDNISOLONE (99)
VINCRISTINE (97)
MYCOPHENOLATE MOFETIL (95)
Which PEMBROLIZUMAB Alternatives Have Lower Systemic inflammatory response syndrome Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G